Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom 
Abstract
Objective-To estimate the cumulative incidence of AIDS by time since seroconversion in haemophiliacs positive for HIV and to examine the evidence for excess mortality associated with HIV in those who had not yet been diagnosed as having AIDS. Design-Analysis of data from ongoing national surveys.
Setting-Haemophilia centres in the United Kingdom.
Patients-A total of 1201 men with haemophilia who had lived in the United Kingdom during 1980-7 and were positive for HIV.
Intervention-None. End points-Diagnosis of AIDS; death in those not diagnosed as having AIDS.
Measurements and main results-Estimation of cumulative incidence of AIDS and number of excess deaths in seropositive patients not diagnosed with AIDS. Median follow up after seroconversion was 5 years 2 months. Eighty five patients developed AIDS. Cumulative incidence of AIDS five years after seroconversion was 4% among patients aged <25 at first test positive for,HIV, 6% among those aged 25-44, and 19% among those aged ¢45. There was little evidence that type or severity of haemophilia or type of factor VIII or IX that had caused HIV infection affected the rate of progression to AIDS. Mortality was increased among those who had not been diagnosed as having AIDS, especially among those with "AIDS related complex." Thirteen deaths were observed among 36 patients diagnosed as having AIDS related complex against 0.65 expected, and 34 deaths in 1080 other patients against 22-77 expected; both calculations were based on mortality rates observed in haemophiliacs in the United Kingdom in the late 1970s.
Conclusions-Rate of progression to AIDS depended strongly on age. There is a substantial burden of fatal disease among patients positive for HIV who have not been formally diagnosed as having AIDS.
Introduction
The proportion of people positive for HIV who proceed to develop serious disease as a result is still uncertain. In this paper information from a recent survey of seroprevalence in haemophiliacs in the United Kingdom was combined with information on the development of AIDS to estimate the cumulative incidence of AIDS by time since seroconversion and its relation with the age of the patient, the type and severity of haemophilia, and the type of factor VIII or IX that gave rise to infection with HIV. In addition, information about mortality was used to assess the evidence for excess mortality among those known to be seropositive for HIV but not diagnosed as having AIDS.
Patients and methods
Information on the numbers of male patients registered with haemophilia A or B who had lived in the United Kingdom in the period Some patients were reported as having only "AIDS related complex" and others who had developed AIDS by the end of the study were reported as having it before they developed AIDS. The precise definition of AIDS related complex has never been clear; many clinicians have now ceased to use the term, and many patients with similar clinical conditions may not have been reported. We have, however, retained the term as we wished to use all the available data both to assist in examining the evidence for increased mortality among those who had not been diagnosed as having AIDS and to confirm that our findings with regard to the differences in latent period according to age were not critically dependent on the precise clinical definition of AIDS. We have therefore divided our calculations of the observed and expected numbers of deaths in those not reported as having AIDS into those few patients reported as having AIDS related complex and those not so reported. We have also repeated our analysis of the cumulative incidence of AIDS to include those reported with AIDS related complex.
Results

CUMULATIVE INCIDENCE OF AIDS FROM ESTIMATED DATE OF SEROCONVERSION
Of the 1201 patients known to be seropositive and for whom a date of first seropositive test was available, 85 were diagnosed as having AIDS. One further patient diagnosed as having AIDS was reported, but as he did not seem to have been tested for HIV in any haemophilia centre he has been excluded from this analysis. Eighty two of the diagnosed cases had haemophilia A and three had haemophilia B. All three of those with haemophilia B and 67 those with haemophilia A had a severe coagulation defect (factor VIII or IX level <2% of normal).
The median follow up time after the estimated date of seroconversion until diagnosis ofAIDS, death, or 31 December 1987 was 5 years 2 months, and only 8% of patients were followed for 6 4 5 only commercial materials in this period. There was no significant difference in the pattern of latent period for AIDS between these two groups of patients (x2=037; p=0 54).
An additional 36 patients with haemophilia A and one patient with haemophilia B were reported as having AIDS related complex but not AIDS. When the analysis was repeated to include these patients the increasing incidence of disease with increasing age at date of first positive test remained and by five years after seroconversion 6%, 10%, and 25% of patients aged <25, 25-44 and ¢s45 respectively had either been diagnosed as having AIDS or reported as having AIDS related complex (see table II and fig 2) . A total of 34 further deaths were reported in patients known to be seropositive for HIV but who had not been diagnosed as having AIDS or AIDS related complex by the time they died. Thirty three of these patients had haemophilia A, 25 being severely affected, and one patient had haemophilia B. Only 22-8 deaths would have been expected if the age specific mortality rates in the group had been the same as that among patients with severe haemophilia A during 1976-80. ' This excess was significant (p=0 017) and was evenly distributed in calendar time. When, however, the observed and expected deaths were examined separately by age a large part of the excess was found to be among those aged 70 years and over, in whom eight deaths were observed compared with only 1-09 expected (table III) The findings give a lower rate of progression to AIDS than has been reported for patients receiving transfusions9 '°and for homosexuals," but they are in agreement with those of a recent study of seven cases of AIDS in 98 haemophijiacs positive for HIV in Sweden in which the cumulative incidence of AIDS five years after seroconversion was estimated to be 5%"' and a study of 10 cases of AIDS in 92 seropositive haemophiliacs in Pennsylvania in which the cumulative five year incidence was about 1 1%.12 In our study haemophiliacs aged over 45 on the date of their earliest seropositive test have almost five times more risk of developing AIDS by five years after seroconversion than those aged under 25. This difference is so pronounced and the evidence for it so strong that it is highly unlikely to be due to any biases or uncertainties in the data. No obvious relation between age at infection and time to occurrence of AIDS was seen in the Swedish data, but in the Pennsylvania series about 5% (two patients) of those aged 2-21 and 18% (eight patients) of those aged 22-64 had developed AIDS. An age effect has also been seen in a larger cohort of 577 haemophiliacs in the United States, in which the Pennsylvania series is included, in whom the annual conditional probability of AIDS five years after seroconversion was estimated to be 2% for those aged under 21 and 5% for those aged at least 21 (J J Goedert et al, fourth international conference on AIDS, Stockholm, 1988) . A survey of 116 haemophilia treatment centres in the United States has also reported that patients with AIDS who attended the centres were older than patients without AIDS.'3 Age related differences in the latent period of AIDS have also been reported among patients receiving transfusions,9 with patients aged 60 and over having an estimated median latent period of 5 44 years against a median of 7-97 years in those aged 5-59; those aged 0-4 at infection had very short latent periods (estimated median 1 90 years). Another study of AIDS associated with transfusion in the United States has reported a mean incubation period of 2-4 years with children'4; for adults it is about 4-5 years. ' Knowledge of normal ventilatory function is particularly important in older people because of their high prevalence of chronic bronchitis and emphysema. We therefore studied additional men aged 55 or over and women aged 65 or over who fulfilled the same selection criteria as in our original study.
In this paper we report new equations for the regression of PEF in men and women which were calculated from the combined data of the original and present studies. We compare the new regressions with those which we reported previously4 and also with those of other workers who did not restrict their series to non-smokers. In a subsidiary study(reported in our accompanying paper5) we used the new equations to investigate the effects of smoking on ventilatory function in elderly men and women who, apart from being smokers or ex-smokers, fulfilled all our other criteria of normality.
Subjects and methods
Between 1975 and 1987 one of us (IG) conducted a search in the course of day to day consultations in two general practices to identify men aged 55 or over, and women aged 65 or over who had never smoked and who denied expectoration, respiratory infection, wheeze, or shortness of breath during childhood or adulthood. The practices, in Kingston upon Thames and Southampton, were similar in their age and social class distribution, and levels of atmospheric pollution were generally low in both areas.
Measurements of PEF were made with three Wright peak flow meters, whose calibration was checked at regular intervals. All the tests were supervised by a single observer (IG), who explained the purpose of the study and then demonstrated the correct manner of performing the test. Subjects were observed while they made several trial attempts in order to detect faults in technique. Once they were able to perform the test correctly they were exhorted to make a maximum effort, and the highest value achieved in three tests in the standing position was recorded to the nearest 5 1/min. Standing height without shoes was measured to the nearest centimetre.
The data from 23 men aged 55 or over and 29 women aged 65 or over who satisfied our criteria of normality were combined with those from the 202 men and 199 women in the original series. In calculating the equations for the regression of PEF on age and height
